Literature DB >> 18309499

[Concepts on the pathogenesis of juvenile idiopathic arthritis].

T Niehues1, O Feyen, T Telieps.   

Abstract

There are various explanations for the development of juvenile idiopathic arthritis (JIA).Gene changes in the immune system can predispose to JIA and regulation of the immune system is crucial in the pathogenesis. The adaptive, acquired immune system probably plays a central role. Thus, in the case of JIA a conspicuous population of highly activated T-cells can be found in the synovia. B-cells are also involved, as indicated by positive ANA titers in JIA patients. Regulatory T-cells (Tregs) attempt to prevent the expansion of autoreactive T-cells.However, the natural or the innate immune system also plays a role. Thus a disorder of the inflammasome could underlie the cause of JIA with systemic onset. The interaction between congenital and adaptive immune system shows that a distinct spatial and temporal separation between the two immune systems is becoming increasingly difficult. An infection- and virus-related immune reaction could also be the cause of JIA. Proinflammatory cytokines are of proven significance in pathogenesis in terms of how they are released under stress, for example. New genomic and proteomic techniques are able to produce individualized profiles for each patient and allow for increasingly fine separation between subtypes, thus improving therapeutic possibilities.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18309499     DOI: 10.1007/s00393-008-0276-7

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  70 in total

1.  Neuroendocrine gene polymorphisms and susceptibility to juvenile idiopathic arthritis.

Authors:  R P Donn; A Farhan; A Stevans; A Ramanan; W E R Ollier; W Thomson
Journal:  Rheumatology (Oxford)       Date:  2002-08       Impact factor: 7.580

Review 2.  Juvenile idiopathic arthritis.

Authors:  Angelo Ravelli; Alberto Martini
Journal:  Lancet       Date:  2007-03-03       Impact factor: 79.321

3.  Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study.

Authors:  Wilco de Jager; Esther P A H Hoppenreijs; Nico M Wulffraat; Lucy R Wedderburn; Wietse Kuis; Berent J Prakken
Journal:  Ann Rheum Dis       Date:  2006-12-14       Impact factor: 19.103

4.  Differential expression patterns of recombination-activating genes in individual mature B cells in juvenile idiopathic arthritis.

Authors:  C Faber; H Morbach; S K Singh; H J Girschick
Journal:  Ann Rheum Dis       Date:  2006-02-27       Impact factor: 19.103

5.  Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis.

Authors:  L R Wedderburn; N Robinson; A Patel; H Varsani; P Woo
Journal:  Arthritis Rheum       Date:  2000-04

6.  Ex vivo apoptosis, CD95 and CD28 expression in T cells of children with juvenile idiopathic arthritis.

Authors:  Sabine Knipp; Oliver Feyen; Jennnifer Ndagijimana; Tim Niehues
Journal:  Rheumatol Int       Date:  2002-12-04       Impact factor: 2.631

7.  CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis.

Authors:  Ismé M de Kleer; Lucy R Wedderburn; Leonie S Taams; Alka Patel; Hemlata Varsani; Mark Klein; Wilco de Jager; Gisela Pugayung; Francesca Giannoni; Ger Rijkers; Salvatore Albani; Wietse Kuis; Berent Prakken
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

8.  The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.

Authors:  D Fishman; G Faulds; R Jeffery; V Mohamed-Ali; J S Yudkin; S Humphries; P Woo
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

9.  Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement.

Authors:  Patricia Woo; Nicholas Wilkinson; Anne-Marie Prieur; Taunton Southwood; Valentina Leone; Polly Livermore; Helena Wythe; David Thomson; Tadamitsu Kishimoto
Journal:  Arthritis Res Ther       Date:  2005-09-15       Impact factor: 5.156

Review 10.  Cells of the synovium in rheumatoid arthritis. T lymphocytes.

Authors:  Steven K Lundy; Sujata Sarkar; Laura A Tesmer; David A Fox
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more
  3 in total

1.  Serum biomarkers for the diagnosis and monitoring of chronic recurrent multifocal osteomyelitis (CRMO).

Authors:  Sigrun Renate Hofmann; Anne Sophie Kubasch; Ursula Range; Martin Walther Laass; Henner Morbach; Hermann Joseph Girschick; Christian Michael Hedrich
Journal:  Rheumatol Int       Date:  2016-03-21       Impact factor: 2.631

2.  Abatacept in difficult-to-treat juvenile idiopathic arthritis.

Authors:  Jasmin B Kuemmerle-Deschner; Sm Benseler
Journal:  Biologics       Date:  2008-12

3.  Production and Secretion of Gelsolin by Both Human Macrophage- and Fibroblast-like Synoviocytes and GSN Modulation in the Synovial Fluid of Patients with Various Forms of Arthritis.

Authors:  Jessica Feldt; Martin Schicht; Jessica Welss; Kolja Gelse; Stefan Sesselmann; Michael Tsokos; Eileen Socher; Fabian Garreis; Thomas Müller; Friedrich Paulsen
Journal:  Biomedicines       Date:  2022-03-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.